M.D. Sass LLC’s Marvell Technology MRVL Stock Holding History

M.D. Sass LLC’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.2M	Sell	67,899 -8,879	-12%	-$1.78M	1.32%	23
2026 Q1	$7.6M	Buy	76,778 +897	+1%	+$75.3K	0.58%	26
2025 Q4	$6.45M	Sell	75,881 -6,158	-8%	-$539K	0.51%	26
2025 Q3	$6.9M	Sell	82,039 -1,394	-2%	-$103K	0.56%	26
2025 Q2	$6.46M	Buy	+83,433	New	+$5.21M	0.52%	24
2025 Q1	–	Sell	-599,096	Closed	-$66.2M	–	37
2024 Q4	$66.2M	Sell	599,096 -460,485	-43%	-$42.7M	4.98%	4
2024 Q3	$76.4M	Buy	1,059,581 +52,200	+5%	+$3.61M	5.66%	6
2024 Q2	$70.4M	Buy	+1,007,381	New	+$70.6M	5.06%	7

Other funds holding MRVL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

M.D. Sass LLC's MRVL Position: Q2 2026 in Review

M.D. Sass LLC reduced its Marvell Technology (MRVL) stake by 12% in Q2 2026, selling an estimated $1.78M and leaving 67,899 shares worth $20.2M. The position accounts for 1.32% of the portfolio, ranked #23.

M.D. Sass LLC first reported a position in MRVL in Q2 2024 and has held it in 8 quarters since. The position peaked at $76.4M in Q3 2024. 2,204 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

M.D. Sass LLC held 67,899 shares of Marvell Technology worth $20.2M as of Q2 2026.
M.D. Sass LLC sold 8,879 Marvell Technology shares in Q2 2026, an estimated $1.78M.
Marvell Technology made up 1.32% of M.D. Sass LLC's portfolio in Q2 2026, its #23 holding.
M.D. Sass LLC first reported a position in Marvell Technology in Q2 2024 and has held it in 8 quarters since.
M.D. Sass LLC's Marvell Technology position peaked at $76.4M in Q3 2024.
2,204 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.